A Study on the Preference of Risperidone Dosage Forms

ConditionsSchizophrenia Bipolar Affective Disorder Autism Spectrum Disorder Conduct Disorder Mental Retardation

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorShanghai Mental Health Center

About this trial

This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study.

Disqualifiers

Have difficulty reading and understanding Chinese or refuse to participate in the study.

Trial population

Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study.

Trial design

Design model

Case-only

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

1,000 Participants

are grouped into 1 trial group

Group A: Patients and their caregivers

Trial outcomes

Primary outcomes

Proportion of patients (and their caregivers) who prefer risperidone patch-form medicine

The proportion of patients (and their caregivers) who preferred risperidone patch among the respondents in this study

Time frame

"through study completion, an average of 6 months

Secondary outcomes

Factors related to patients' preference for risperidone patch-form medicines

Patients' evaluation of the importance of each advantage of risperidone patch in a self-made questionnaire (5-point Likert scale score)

Time frame

through study completion, an average of 6 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Shanghai Mental Health Center

Lead sponsor

Source ClinicalTrials.gov

Apply now